Literature DB >> 17021685

Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up.

S da Pozzo1, R Manara, S Tonello, C Carollo.   

Abstract

PURPOSE: Progressive multifocal leukoencephalopathy (PML) is a serious disorder that primarily affects individuals with a suppressed immune system. Few semiological elements help clearly distinguish PML from other diseases included in the differential diagnosis. Moreover, the clinical course of disease may be chronic or rapidly progressive, with different magnetic resonance imaging (MRI) patterns. The purpose of this study was to confirm the diagnostic value of conventional MRI sequences combined with diffusion-weighted imaging (DWI) in PML to identify those patients with worst prognosis.
MATERIALS AND METHODS: We used both conventional MRI sequences and DWI to monitor four male patients aged between 40 and 50 years affected by PML. In two patients, the disease rapidly led to death whereas the other two patients presented a chronic course.
RESULTS: Conventional MRI sequences enable detection of the extension of white matter lesions. DWI permits more accurate differentiation of the disease progression front, which exhibits low signal intensity in apparent diffusion coefficient (ADC) maps, from the central gliotic area of demyelinisation, characterised by high ADC values. Patients with rapidly evolving PML have a clear progression front on DWI, which seems to be very tenuous, if not absent, during the quiescent phases of the disease.
CONCLUSIONS: The addition of DWI sequences to conventional MRI seems to be a valid method for accurately diagnosing PML and establishing the degree of disease progression.

Entities:  

Mesh:

Year:  2006        PMID: 17021685     DOI: 10.1007/s11547-006-0095-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  6 in total

1.  Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.

Authors:  David B Clifford; Beau Ances; Craig Costello; Shari Rosen-Schmidt; Magnus Andersson; Deborah Parks; Arie Perry; Raju Yerra; Robert Schmidt; Enrique Alvarez; Kenneth L Tyler
Journal:  Arch Neurol       Date:  2011-05-09

Review 2.  Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.

Authors:  Justin M Honce; Lidia Nagae; Eric Nyberg
Journal:  Mult Scler Int       Date:  2015-09-21

3.  High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.

Authors:  Claudia Godi; Enrico De Vita; Enrico Tombetti; Indran Davagnanam; Lewis Haddow; Hans Rolf Jäger
Journal:  Eur Radiol       Date:  2017-02-06       Impact factor: 5.315

4.  Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.

Authors:  Guglielmo Manenti; Simone Altobelli; Marco Nezzo; Marco Antonicoli; Erald Vasili; Luca Neroni; Roberto Floris; Giovanni Simonetti
Journal:  Case Rep Radiol       Date:  2013-03-10

5.  Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy.

Authors:  M Cosottini; C Tavarelli; L Del Bono; G Doria; M Giannelli; S De Cori; M C Michelassi; C Bartolozzi; L Murri
Journal:  Eur Radiol       Date:  2008-03-07       Impact factor: 7.034

6.  Understanding progressive multifocal leukoencephalopathy: links between milky-way appearance and mismatch T2/FLAIR.

Authors:  Emiliano Ruiz Romagnoli; Manuel Perez Akly; Luis A Miquelini; Jorge Funes; Tatiana Gillanders; Cristina Besada
Journal:  Neuroradiol J       Date:  2021-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.